Your browser doesn't support javascript.
loading
Topical application of TAK1 inhibitor encapsulated by gelatin particle alleviates corneal neovascularization.
Wang, Jiang-Hui; Tseng, Ching-Li; Lin, Fan-Li; Chen, Jinying; Hsieh, Erh-Hsuan; Lama, Suraj; Chuang, Yu-Fan; Kumar, Satheesh; Zhu, Linxin; McGuinness, Myra B; Hernandez, Jessika; Tu, Leilei; Wang, Peng-Yuan; Liu, Guei-Sheung.
Affiliation
  • Wang JH; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
  • Tseng CL; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
  • Lin FL; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Chen J; Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • Hsieh EH; Department of Ophthalmology, the First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Lama S; Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
  • Chuang YF; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Kumar S; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Zhu L; Shenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • McGuinness MB; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Hernandez J; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
  • Tu L; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.
  • Wang PY; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Liu GS; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Theranostics ; 12(2): 657-674, 2022.
Article in En | MEDLINE | ID: mdl-34976206
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resorcinols / Endothelium, Vascular / Corneal Neovascularization / MAP Kinase Kinase Kinases / Lactones Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Theranostics Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Resorcinols / Endothelium, Vascular / Corneal Neovascularization / MAP Kinase Kinase Kinases / Lactones Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Theranostics Year: 2022 Document type: Article Affiliation country: Australia Country of publication: Australia